Composing milestones innovation overview

Milestones & Innovation

The company's Success Today is the Result of It's Healthy Roots

Innovations are a major driver of future growth

Research and development plays an important role within the Carl Zeiss Meditec Group. Our objective is to enable our customers and physicians to continuously improve treatment results through improvements in efficiency and innovative new products.

Carl Zeiss Meditec Group has the necessary resources to secure the Company’s future earnings strength with its research and development activities. Thus we also want to offer innovations in future that make leading technologies available for our customers, and thus improve treatment results for patients.

Research and development at the Company mainly focuses on:

  • examining new technological concepts in terms of their clinical relevance and effectiveness,
  • the continuous development of the existing product portfolio,
  • the development of new products and product platforms based on the available basic technologies and
  • networking systems and equipment to increase the efficiency of diagnosis and treatment and to improve treatment results for patients.


The long and successful history is marked with numerous milestones and innovations that have enabled the company to drive the progress of medical technology. Several of these products, and how the latest developments shape the future, are presented on the following pages.


2014: CT LUCIA

ZEISS offers an extensive range of hydrophilic intraocular lenses and with the launch of the hydrophobic monofocal intraocular lens CT LUCIA® one of the most comprehensive IOL portfolios on the market.


2014: IOLMaster 700

The IOLMaster® 700 with SWEPT Source Biometry™ enables physicians to identify irregular geometries of the eye in their patients at an early stage. In addition to optical biometry, it also offers OCT9 imaging across the entire length of the eye. Experts say that this produces more reliable refractive results.  


2014: OPMI LUMERA 700 and Rescan 700

This system for integrated intraoperative OCT imaging combines two of the Company’s gold standard technologies. The system incorporates the OPMI LUMERA® 700 surgical microscope with the integrated OCT camera RESCAN™ 700. The system provides surgeons with top-quality OCT images of the eye, intraoperatively.


2012: AT LISA family

AT LISA® and AT LISA® tri are part of the a new generation of high-performance multifocal IOLs.


2006: VisuMax

Also on its way to becoming a new standard: the VisuMax® femtosecond laser. Surgeons have been successfully using this system since 2006.



INTRABEAM® is an innovative system for breast cancer and is tested in numerous clinical studies.


1999: IOLMaster

Today, selecting the right IOL to meet individual patient expectations is more crucial than ever. The IOLMaster® incorporates advancements designed with the challenges of today’s cataract practice in mind.


1997: OCT 1

Introduced in 1997, optical coherence tomography (OCT) from assists doctors in the examination of patients with serious diseases of the retina.

Carl Zeiss hfa perimeter

1984: HFA Perimeter

Since 1984, the HFA has been the accepted standard of care in glaucoma diagnosis and management, validated by many years of research design and clinical experience.

Carl Zeiss photocoalugator year1957

1957: Photocoagulator

The Photocoagulator is designed to provide eye doctors of various disciplines and backgrounds optimum flexibility for a broad spectrum of retinal therapies.

1953: OPMI

The first prototypes of the first surgical microscope, the ZEISS OPMI® 1, were developed in the early the 1950s under the guidance of physicist Hans Littmann.


1911: Slit Lamp

ZEISS developed the first slit lamp together with Swedish doctor Allvar Gullstrand. This development laid the foundation for medical technology at Carl Zeiss.